Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-06-021321
Filing Date
2006-03-31
Accepted
2006-03-31 16:33:34
Documents
10
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT PURSUANT TO SECTION 13 AND 15(D) a06-6800_110k.htm 10-K 3167750
2 CONSENTS OF EXPERTS AND COUNSEL a06-6800_1ex23d1.htm EX-23.1 2181
3 302 CERTIFICATION a06-6800_1ex31d1.htm EX-31.1 6523
4 302 CERTIFICATION a06-6800_1ex31d2.htm EX-31.2 6371
5 906 CERTIFICATION a06-6800_1ex32d1.htm EX-32.1 5604
6 GRAPHIC g68001dci001.jpg GRAPHIC 37088
7 GRAPHIC g68001dci002.jpg GRAPHIC 29236
8 GRAPHIC g68001dci003.jpg GRAPHIC 23368
9 GRAPHIC g68001dci004.jpg GRAPHIC 19914
10 GRAPHIC g68001dai001.jpg GRAPHIC 24933
  Complete submission text file 0001104659-06-021321.txt   3375782
Mailing Address
Business Address 15 SKYLINE DRIVE HAWTHORNE NY 10532 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000
Type: 10-K | Act: 34 | File No.: 000-50513 | Film No.: 06729369
SIC: 2836 Biological Products, (No Diagnostic Substances)